Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker. Órpez-Zafra T, Pavía J, Hurtado-Guerrero I, Pinto-Medel MJ, Rodriguez Bada J L, Urbaneja P, Suardíaz M, Villar LM, Comabella M, Montalban X, et al. Mult Scler. 2016 Sep 9. PMID: 27613121. Abstract CommentRecommendBookmarkWatch